Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 5710
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70978
So if you have migraines or certain heart
(3)
Drano
12/27/2021 12:07:13 AM
70977
Ritonavir, part of part of Pfizer's covid pill
(5)
farrell
12/26/2021 11:43:01 PM
70976
Great post farrell. We have all read about safety
(6)
Mo
12/26/2021 11:49:20 AM
70975
At this point none of the other antiviral drugs
(11)
farrell
12/26/2021 10:59:11 AM
70972
Thanks and same to you and the board as well.
(3)
Kelt
12/25/2021 3:14:01 PM
70968
Second the motion. Merry Christmas and let's hope
(5)
Drano
12/25/2021 11:02:42 AM
70967
Merry Christmas to you and all who
(5)
someconcerns
12/25/2021 6:31:36 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
70903
I agree Glad to finally hear from you.
(2)
Kelt
11/22/2021 7:56:04 PM
70899
Besides trying to hide the real issues with this
(6)
falcon74
11/18/2021 12:53:47 PM
70898
copy of my PM .. just now .. to another IPIX
(13)
4kids
11/18/2021 11:19:21 AM
70897
As noted previously, trial analysis is "ongoing"
(3)
bandg
11/18/2021 11:03:44 AM
Newer
Older
Recent Articles
Altimmune to Showcase Innovations at Key Investor Conferences
NeuroNOS Welcomes Nobel Laureate Roger D. Kornberg to Board
BriaCell Highlights New Survival Data in Metastatic Breast Cancer
Jim Cramer Highlights Linde's Potential Amid Stock Surge
Brazil's Rising Inflation Signals Potential Rate Hikes Ahead
Nano Dimension Encourages Shareholders to Support Board Changes
Nigeria's Central Bank Adjusts Key Interest Rate to 27.50%
Rivian Automotive's Strategic $6.6 Billion DOE Loan Boosts Shares
H&M Faces Challenges Amid RBC Downgrade and Market Pressures
S&P 500 Expected to Surge 8% by 2025 Supported by Rate Cuts
Charles Hoskinson Envisions Cardano Revolutionizing Bitcoin
Exploring Promising Solar Investments Amid Political Changes
Investors Alert: Class Action Lawsuit Filed Against Zeta Global
Leslie's Faces Tough Market After Disappointing Earnings Report
Market Watch: Analyst Downgrades That Could Affect Your Portfolio
Warning Signs for These Three Industrials Stocks This Quarter
Transforming Solar Access: The Impact of TAG's Innovations
Exciting Treehouse Hotel Silicon Valley Now Open for Bookings
Exploring Antimony's Price Surge: Impacts on Industry and Investment
NEXE Innovations Partners with Bridgehead Coffee for Growth
Leadership Changes at Northstar Aim to Fuel Future Growth
Innovative Waveguide Smart Glasses by Vuzix at CES 2025
Google's AdTech Trial Closes with High Stakes Arguments
Intel Secures Nearly $8 Billion for Semiconductor Growth
US Building Permits Show Signs of Stabilization Amid Decline
Best Buy Reports Q3 Performance and Adjusted Future Expectations
VerifyMe Expands Share Buyback Program Through 2025
H World Group Limited Reports Q3 2024 Financial Highlights
Esperion's Innovative Cholesterol Drug Seeks Approval in Japan
Eos Energy Partners with Wabash for Enhanced Battery Solutions
Sonder Holdings Faces Nasdaq Compliance Challenges Ahead
OpenText Welcomes Cisco Leader to Enhance Board Dynamics
Xeros Technology Group Sees Major Shift in Shareholdings
Shareholder Meetings Set for Fondul Proprietatea’s Board Nominees
TOYO Co. Secures Major Solar Cell Contract Boosting Future
UroGen Pharma's JELMYTO: A Revolutionary Long-term Treatment
Maxeon Solar's Strategic Shift: Emphasizing U.S. Operations
Barclays Warns of Potential Market Bubble Following Elections
Wells Fargo's Path to Removing Asset Cap: Key Insights Ahead
Auto Industry Reacts to Trump's Proposed Tariffs on Imports
Cabaletta Bio: Upcoming Conferences for Investors Wisdom
Freshworks Takes Center Stage at UBS Global Technology Event
Renexxion Ireland Ltd. Expands Intellectual Property Portfolio
Gentex Corporation Declares Quarterly Dividend for Investors
Keros Therapeutics to Present Key Developments at Conferences
X4 Pharmaceuticals to Showcase Innovations at Notable Conference
ALX Oncology Leadership to Speak at Upcoming Healthcare Event
Tria Federal Welcomes Michael Anderson as Executive VP for Safety
Significant Growth Forecast for Smart Sensor Market through 2031
TOYO Co., Ltd's $150 Million Contract to Supply Solar Cells